Liposomal Amphotericin B Can Safely Be Administered in Paediatric Outpatients with Cancer for the Primary or Secondary Prevention of Invasive Aspergillosis

Publisher： Karger

E-ISSN： 1421-9662|118|2|68-69

ISSN： 0001-5792

Source： Acta Haematologica, Vol.118, Iss.2, 2007-05, pp. : 68-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 2, 2015-07 ,pp. : 420-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Invasive Pulmonary Aspergillosis in Neutropenic Patients by Additional Bronchoscopic Amphotericin B Instillation

By  

Respiration, Vol. 74, Iss. 6, 2007-07 ,pp. : 663-673

Karger

Access to resources Recommend Favorite

Adjuvant Endobronchial Amphotericin B for Refractory Invasive Pulmonary Aspergillosis: Evidence Is Scarce but Promise Does Exist

By  

Respiration, Vol. 74, Iss. 6, 2006-09 ,pp. : 609-610

Karger

Access to resources Recommend Favorite

Successful Treatment of Invasive Pulmonary Aspergillosis by Transbronchial Injection of Urinary Trypsin Inhibitor and Amphotericin B

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 156-157

Karger

Access to resources Recommend Favorite

Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 111-118

Karger

Access to resources Recommend Favorite